An auto-immune reaction that cannot occur intramuscularously, unless a vein has been hit: "
In the event of intravenous injection, adenovirus is found in the blood, while intracellular, it would have infected muscle cells and would not have been in the blood flow", Billy continues. He goes on: "
in the blood, it is found with other cells, that rule the blood flow, the veins' permeability, all-thing blood homeostasis and therefore thrombotic ability".
How to know if the intramuscular injection worked or not? A very simple manipulation, when back from the injection, the group recommends to "
check for the absence of blood flow during vaccination".
Rare blood clots past the injection
This Tuesday March 30, immunology lecturer and Head of the vaccinal strategy guidance committee Alain Fischer told our peers from
France Inter about what could explain the creation of blood clots: "
Several European teams - including Germans - have highlighted people who developed, five to fifteen days later, complications as thrombosis, a small decrease in platelets, and coagulation failure, what we call disseminated intravascular coagulation", he said.
He went on: "
they found self-antibodies causing the platelets to stick together. This is what causes the abnormal formation of clot". He concluded: "
This antibody probably is a marker of this complication, but we have left to see if there is a causal link with the vaccine".
As for the study thoroughly conducted in Norway after a young and health caretaker died ten days after being vaccinated with
AstraZeneca, to brain hemorrhage, without clear link between her situation and the inoculation of the vaccine. As for the European regulator, the investigation goes on anyway. During a press brief on Thursday March 18, the EMA also stated that even though vaccinations were allowed to resume, it was required to show on leaflets given to people recently vaccinated that thromboses were likely to occur.
In France,
AstraZeneca vaccination has resumed but remains limited to people over 55 years of age.